C2 Pharma Menu
  • Products
      • c2p_navi_products_APIsProducts Image
      • Products
      • APIs
      • R&D PIPELINE
  • Services
  • Company
      • c2pharma_navi_aboutCompany Image
      • Company
      • ABOUT US
      • NETWORK
      • CAREERS
  • News
  • Contact

Author: admin_c2p

C2 PHARMA Receives CEP approval for Oxybuprocaine Hydrochloride

Posted on 28. January 202528. January 2025 by admin_c2p
Posted in Press Release

C2 PHARMA Marks 10th Year Anniversary Attendance at CPhI Milan with Expanded Ophthalmic API Portfolio

Posted on 24. September 202424. September 2024 by admin_c2p
Posted in General

C2 PHARMA EXPANDS OPHTHALMIC API PORTFOLIO WITH NAPHAZOLINE HYDROCHLORIDE LAUNCH

Posted on 12. September 2024 by admin_c2p
Posted in General

C2 PHARMA Receives CEP Approval For Tropicamide

Posted on 30. July 202430. July 2024 by admin_c2p
Posted in Press Release

C2 PHARMA’s Upcoming Launch of Oxybuprocaine Hydrochloride

Posted on 6. March 20246. March 2024 by admin_c2p
Posted in Press Release

C2 PHARMA x PharmaSource Ophthalmics Buyer Guide

Posted on 15. February 202415. February 2024 by admin_c2p
Posted in General

C2 PHARMA Receives DMF Approval in China for Pilocarpine Nitrate

Posted on 21. November 202322. November 2023 by admin_c2p
Posted in Press Release

Manufacturing Chemist StandSide interview with C2 PHARMA’s CEO at CPHI WW Barcelona

Posted on 7. November 20237. November 2023 by admin_c2p
Posted in Video

Optimizing the Total Cost of Ownership by C2 PHARMA’s CEO, Andrew Badrot

Posted on 30. October 202330. October 2023 by admin_c2p
Posted in General

Senior Manager Business Development, Serge Tarabay PharmaSource Podcast Interview

Posted on 18. October 202318. October 2023 by admin_c2p
Posted in podcast

C2 PHARMA Expands API Portfolio with Global Regulatory Access Ahead of CPhI Barcelona

Posted on 17. October 202317. October 2023 by admin_c2p
Posted in Press Release

Head of Quality, Tara Fitzpatrick Interviews with Pharma Techs Felicity Thomas

Posted on 2. October 2023 by admin_c2p
Posted in Video

Celebrating a Milestone: Cyclopentolate CEP approval

Posted on 6. July 2023 by admin_c2p
Posted in General

EDQM Grants C2 PHARMA CEP Approval for Commercial Sale of Cyclopentolate Hydrochloride

Posted on 27. June 202327. June 2023 by admin_c2p
Posted in Press Release

C2 PHARMA Receives Approval for Digoxin China DMF, Becoming China’s Only European Supplier of This API

Posted on 13. June 202327. June 2023 by admin_c2p
Posted in Press Release

Recent Posts

  • C2 PHARMA Receives CEP approval for Oxybuprocaine Hydrochloride
  • C2 PHARMA Marks 10th Year Anniversary Attendance at CPhI Milan with Expanded Ophthalmic API Portfolio
  • C2 PHARMA EXPANDS OPHTHALMIC API PORTFOLIO WITH NAPHAZOLINE HYDROCHLORIDE LAUNCH
  • C2 PHARMA Receives CEP Approval For Tropicamide
  • C2 PHARMA’s Upcoming Launch of Oxybuprocaine Hydrochloride

Archives

  • January 2025
  • September 2024
  • July 2024
  • March 2024
  • February 2024
  • November 2023
  • October 2023
  • July 2023
  • June 2023
  • March 2023
  • February 2023
  • November 2022
  • October 2022
  • August 2022
  • November 2021
  • April 2021
  • February 2021
  • December 2020
  • November 2020
  • September 2020
  • August 2020
  • July 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • September 2019
  • July 2019
  • June 2019
  • March 2019
  • November 2018
  • October 2018
  • June 2018
  • October 2017
  • September 2017
  • September 2016
  • October 2015
  • September 2015
  • May 2015
  • March 2015
  • September 2014

Categories

  • General
  • Information Brief
  • podcast
  • Press Release
  • Video

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • APIs

    • Atropine Sulfate
    • Bimatoprost
    • Brimonidine Tartrate
    • Cyclopentolate Hydrochloride
    • Digoxin
    • Digoxin Micronized
    • Homatropine Hydrobromide
    • Homatropine Methylbromide
    • Latanoprost
    • Naphazoline Hydrochloride
    • Oxybuprocaine Hydrochloride
    • Pilocarpine Hydrochloride
    • Pilocarpine Nitrate
    • Tropicamide
  • R&D Pipeline
  • Services
  • About Us
  • Network
  • Careers
  • News
Irish Green Logo 2024
  • CONTACT

info@c2pharma.com
C2Pharma Logo
  • General Terms of Sales
  • Data Privacy